Heilongjiang Tianlong Pharmaceutical

Heilongjiang Tianlong Pharmaceutical is a specialty pharmaceutical company based in Harbin, China, that focuses on the development, manufacturing, and distribution of topical and external-use medications. Founded in 1993, the company has established itself as a leading "Expert in External Medications," producing a wide range of dosage forms including suppositories, creams, gels, and sprays. Its therapeutic focus spans gynecology, dermatology, pediatrics, and orthopedics, with key products such as Policresulen Vaginal Suppository and various antifungal treatments. In 2008, the company was acquired by China Sky One Medical, which expanded its R&D and manufacturing capabilities. Beyond its core topical portfolio, Tianlong is involved in the development of traditional Chinese medicine (TCM) and has explored advanced therapies like NK cell and mesenchymal stem cell treatments. The company operates GMP-certified facilities and maintains a significant market presence in Northeast and Northwest China, while also exporting to international markets.